{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:04:57Z","timestamp":1793639097477,"version":"4.5.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Since their invention 40\u00a0years ago, totally implantable venous-access ports (TIVAPs) have become indispensable in cancer treatment. The aim of our study was to analyze complications under standardized operative and perioperative procedures and to identify risk factors for premature port catheter explantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1008 consecutive TIVAP implantations were studied for success rate, perioperative, early, and late complications. Surgical, clinical, and demographic factors were analyzed as potential risk factors for emergency port catheter explantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Successful surgical TIVAP implantation was achieved in 1005\/1008 (99.7%) cases. No intraoperative or perioperative complications occurred. A total of 32 early complications and 88 late complications were observed leading to explantation in 11\/32 (34.4%) and 34\/88 (38.6%) cases, respectively. The most common complications were infections in 4.7% followed by thrombosis in 3.6%. Parameters that correlated with unplanned TIVAP explantation were gender (port in situ: female 95% vs. male 91%, <jats:italic>p<\/jats:italic>\u2009=\u20090.01), underlying disease (breast cancer 97% vs. gastrointestinal 89%, <jats:italic>p<\/jats:italic>\u2009=\u20090.004), indication (chemotherapy 95% vs. combination of chemotherapy and parenteral nutrition 64%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), and type of complication (infection 13.4% vs. TIVAP-related complication 54% and thrombosis 95%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Standardized operative and perioperative TIVAP implantation procedures provide excellent results and low explantation rate.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00423-022-02656-9","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T08:03:54Z","timestamp":1662537834000},"page":"3755-3762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports\u2014a complication analysis of more than 1000 TIVAP implantations"],"prefix":"10.1007","volume":"407","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-7589","authenticated-orcid":false,"given":"Karolin","family":"Thiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kalmbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6rte","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-7708","authenticated-orcid":false,"given":"Martin","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-4080","authenticated-orcid":false,"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-4860","authenticated-orcid":false,"given":"Christian","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"2656_CR1","first-page":"706","volume":"92","author":"JE Niederhuber","year":"1982","unstructured":"Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706\u2013712","journal-title":"Surgery"},{"key":"2656_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S1473-3099(13)70266-4","volume":"14","author":"D Lebeaux","year":"2014","unstructured":"Lebeaux D, Fernandez-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B, Beloin C (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146\u2013159","journal-title":"Lancet Infect Dis"},{"key":"2656_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/annonc\/mdm272","volume":"19","author":"S Vescia","year":"2008","unstructured":"Vescia S, Baumgartner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S, Harbeck N (2008) Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19:9\u201315","journal-title":"Ann Oncol"},{"key":"2656_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.clnu.2009.03.015","volume":"28","author":"M Pittiruti","year":"2009","unstructured":"Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M, Espen, (2009) ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 28:365\u2013377","journal-title":"Clin Nutr"},{"key":"2656_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/annonc\/mdt545","volume":"25","author":"M Hentrich","year":"2014","unstructured":"Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender H, Wolf HH, Christopeit M, Neumann S, Maschmeyer G, Karthaus M, Infectious Diseases Working Party of the German Society of H, Medical O (2014) Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. Ann Oncol 25:936\u2013947","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"2656_CR6","doi-asserted-by":"publisher","first-page":"v152","DOI":"10.1093\/annonc\/mdv296","volume":"26","author":"B Sousa","year":"2015","unstructured":"Sousa B, Furlanetto J, Hutka M, Gouveia P, Wuerstlein R, Mariz JM, Pinto D, Cardoso F, Committee EG (2015) Central venous access in oncology: ESMO Clinical Practice Guidelines. Ann Oncol 26(Suppl 5):v152-168","journal-title":"Ann Oncol"},{"key":"2656_CR7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/bjs.6730","volume":"96","author":"A Nocito","year":"2009","unstructured":"Nocito A, Wildi S, Rufibach K, Clavien PA, Weber M (2009) Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports. Br J Surg 96:1129\u20131134","journal-title":"Br J Surg"},{"key":"2656_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1148\/radiology.184.1.1609072","volume":"184","author":"SL Morris","year":"1992","unstructured":"Morris SL, Jaques PF, Mauro MA (1992) Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology 184:149\u2013151","journal-title":"Radiology"},{"key":"2656_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S1051-0443(97)70699-7","volume":"8","author":"PC Shetty","year":"1997","unstructured":"Shetty PC, Mody MK, Kastan DJ, Sharma RP, Burke MW, Venugopal C, Burke TH (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991\u2013995","journal-title":"J Vasc Interv Radiol"},{"key":"2656_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-2007-1015051","volume":"169","author":"A Kluge","year":"1998","unstructured":"Kluge A, Stroh H, Wagner D, Rauber K (1998) The fluoroscopy-guided implantation of subcutaneous venous ports: the complications and long-term results. Rofo 169:63\u201367","journal-title":"Rofo"},{"key":"2656_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s002700001721","volume":"24","author":"H Lorch","year":"2001","unstructured":"Lorch H, Zwaan M, Kagel C, Weiss HD (2001) Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients. Cardiovasc Intervent Radiol 24:180\u2013184","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2656_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1051-0443(97)70537-2","volume":"8","author":"KR Simpson","year":"1997","unstructured":"Simpson KR, Hovsepian DM, Picus D (1997) Interventional radiologic placement of chest wall ports: results and complications in 161 consecutive placements. J Vasc Interv Radiol 8:189\u2013195","journal-title":"J Vasc Interv Radiol"},{"key":"2656_CR13","first-page":"323","volume":"159","author":"JR Torramade","year":"1993","unstructured":"Torramade JR, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Gonzalez J, Balen E, de Villa V (1993) The complications of central venous access systems: a study of 218 patients. Eur J Surg 159:323\u2013327","journal-title":"Eur J Surg"},{"key":"2656_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archsurg.136.9.1050","volume":"136","author":"I Di Carlo","year":"2001","unstructured":"Di Carlo I, Cordio S, La Greca G, Privitera G, Russello D, Puleo S, Latteri F (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050\u20131053","journal-title":"Arch Surg"},{"key":"2656_CR15","first-page":"673","volume":"50","author":"SJ Davis","year":"1984","unstructured":"Davis SJ, Thompson JS, Edney JA (1984) Insertion of Hickman catheters. A comparison of cutdown and percutaneous techniques. Am Surg 50:673\u2013676","journal-title":"Am Surg"},{"key":"2656_CR16","first-page":"638","volume":"55","author":"FC Au","year":"1989","unstructured":"Au FC (1989) The anatomy of the cephalic vein. Am Surg 55:638\u2013639","journal-title":"Am Surg"},{"key":"2656_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00330-010-2045-7","volume":"21","author":"UK Teichgraber","year":"2011","unstructured":"Teichgraber UK, Kausche S, Nagel SN, Gebauer B (2011) Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol 21:1224\u20131232","journal-title":"Eur Radiol"},{"key":"2656_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00520-017-3816-3","volume":"26","author":"E Voog","year":"2018","unstructured":"Voog E, Campion L, du Rusquec P, Bourgeois H, Domont J, Denis F, Emmanuel E, Dupuis O, Ganem G, Lafont C, Le Du K, Pavluc E, Pointreau Y, Roche S, Juhel-Voog L, Zinger M, Solal-Celigny P (2018) Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Support Care Cancer 26:81\u201389","journal-title":"Support Care Cancer"},{"key":"2656_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3892\/mco.2016.726","volume":"4","author":"LI Ma","year":"2016","unstructured":"Ma LI, Liu Y, Wang J, Chang Y, Yu L, Geng C (2016) Totally implantable venous access port systems and associated complications: a single-institution retrospective analysis of 2,996 breast cancer patients. Mol Clin Oncol 4:456\u2013460","journal-title":"Mol Clin Oncol"},{"key":"2656_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/S1516-31802004000400003","volume":"122","author":"N Wolosker","year":"2004","unstructured":"Wolosker N, Yazbek G, Nishinari K, Malavolta LC, Munia MA, Langer M, Zerati AE (2004) Totally implantable venous catheters for chemotherapy: experience in 500 patients. Sao Paulo Med J 122:147\u2013151","journal-title":"Sao Paulo Med J"},{"key":"2656_CR21","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1245\/s10434-007-9783-z","volume":"15","author":"L Fischer","year":"2008","unstructured":"Fischer L, Knebel P, Schroder S, Bruckner T, Diener MK, Hennes R, Buhl K, Schmied B, Seiler CM (2008) Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients. Ann Surg Oncol 15:1124\u20131129","journal-title":"Ann Surg Oncol"},{"key":"2656_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3348\/kjr.2014.15.4.494","volume":"15","author":"J Shim","year":"2014","unstructured":"Shim J, Seo TS, Song MG, Cha IH, Kim JS, Choi CW, Seo JH, Oh SC (2014) Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol 15:494\u2013500","journal-title":"Korean J Radiol"},{"key":"2656_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1129729818758999","volume":"19","author":"F Pinelli","year":"2018","unstructured":"Pinelli F, Cecero E, Degl\u2019Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M (2018) Infection of totally implantable venous access devices: a review of the literature. J Vasc Access 19:230\u2013242","journal-title":"J Vasc Access"},{"key":"2656_CR24","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1245\/s10434-014-3784-5","volume":"21","author":"R Biffi","year":"2014","unstructured":"Biffi R, Pozzi S, Bonomo G, Della Vigna P, Monfardini L, Radice D, Rotmensz N, Zampino MG, Fazio N, Orsi F (2014) Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial. Ann Surg Oncol 21:3725\u20133731","journal-title":"Ann Surg Oncol"},{"key":"2656_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10434-000-0496-9","volume":"7","author":"SP Povoski","year":"2000","unstructured":"Povoski SP (2000) A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients. Ann Surg Oncol 7:496\u2013502","journal-title":"Ann Surg Oncol"},{"key":"2656_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.24953\/turkjped.2016.02.010","volume":"58","author":"S Kilic","year":"2016","unstructured":"Kilic S, Soyer T, Karnak I, Ciftci AO, Tanyel FC, Senocak ME (2016) Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study. Turk J Pediatr 58:187\u2013194","journal-title":"Turk J Pediatr"},{"key":"2656_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.medmal.2015.12.006","volume":"46","author":"M Vidal","year":"2016","unstructured":"Vidal M, Genillon JP, Forestier E, Trouiller S, Pereira B, Mrozek N, Aumeran C, Lesens O (2016) Outcome of totally implantable venous-access port-related infections. Med Mal Infect 46:32\u201338","journal-title":"Med Mal Infect"},{"key":"2656_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3348\/kjr.2012.13.3.314","volume":"13","author":"SJ Ahn","year":"2012","unstructured":"Ahn SJ, Kim HC, Chung JW, An SB, Yin YH, Jae HJ, Park JH (2012) Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center. Korean J Radiol 13:314\u2013323","journal-title":"Korean J Radiol"},{"key":"2656_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345","journal-title":"Clin Infect Dis"},{"key":"2656_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jvsv.2015.10.008","volume":"4","author":"AE Zerati","year":"2016","unstructured":"Zerati AE, Figueredo TR, de Moraes RD, da Cruz AM, da Motta-Leal Filho JM, Freire MP, Wolosker N, de Luccia N (2016) Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients. J Vasc Surg Venous Lymphat Disord 4:200\u2013205","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"2656_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/pbc.26225","volume":"64","author":"MR Viana Taveira","year":"2017","unstructured":"Viana Taveira MR, Lima LS, de Araujo CC, de Mello MJ (2017) Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: a cohort study. Pediatr Blood Cancer 64:336\u2013342","journal-title":"Pediatr Blood Cancer"},{"key":"2656_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000151393","volume":"74","author":"P Samaras","year":"2008","unstructured":"Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC (2008) Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology 74:237\u2013244","journal-title":"Oncology"},{"key":"2656_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11604-014-0375-0","volume":"33","author":"S Okada","year":"2015","unstructured":"Okada S, Shiraishi A, Yamashiro Y, Inoue T, Tsuge D, Aida M, Kuwatsuru R (2015) A retrospective statistical analysis of the late complications associated with central venous port placements. Jpn J Radiol 33:21\u201325","journal-title":"Jpn J Radiol"},{"key":"2656_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1086\/598620","volume":"29","author":"SH Zinner","year":"1999","unstructured":"Zinner SH (1999) Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 29:490\u2013494","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2656_CR35","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1086\/383048","volume":"39","author":"R Ramphal","year":"2004","unstructured":"Ramphal R (2004) Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39(Suppl 1):S25-31","journal-title":"Clin Infect Dis"},{"key":"2656_CR36","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/annonc\/mdp052","volume":"20","author":"P Debourdeau","year":"2009","unstructured":"Debourdeau P, KassabChahmi D, Le Gal G, Kriegel I, Desruennes E, Douard MC, Elalamy I, Meyer G, Mismetti P, Pavic M, Scrobohaci ML, Levesque H, Renaudin JM, Farge D, working group of the SOR (2009) 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol 20:1459\u20131471","journal-title":"Ann Oncol"},{"key":"2656_CR37","first-page":"CD006468","volume":"6","author":"LA Kahale","year":"2018","unstructured":"Kahale LA, Tsolakian IG, Hakoum MB, Matar CF, Barba M, Yosuico VE, Terrenato I, Sperati F, Schunemann H, Akl EA (2018) Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev 6:CD006468","journal-title":"Cochrane Database Syst Rev"},{"key":"2656_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jth.12071","volume":"11","author":"P Debourdeau","year":"2013","unstructured":"Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Buller HR, Bounameaux H (2013) International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 11:71\u201380","journal-title":"J Thromb Haemost"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-022-02656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-022-02656-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-022-02656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T04:45:57Z","timestamp":1670301957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-022-02656-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2656"],"URL":"https:\/\/doi.org\/10.1007\/s00423-022-02656-9","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"2 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}